Downregulated microRNA-148b in Circulating PBMCs in Chronic Myeloid Leukemia Patients With Undetectable Minimal Residual Disease: A Possible Biomarker to Discontinue Imatinib Safely
Drug Design, Development and Therapy - New Zealand
doi 10.2147/dddt.s66812
Full Text
Open PDFAbstract
Available in full text
Date
August 1, 2014
Authors
Publisher
Informa UK Limited